Praxis Precision Medicine (NASDAQ:PRAX) reported quarterly earnings results on February 19, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-3.50, missing the consensus estimate of $-3.08 by $0.42 per share. Revenue came in at , missing the estimate of $256.1K.
Praxis Precision Medicine's stock moved following the earnings release. The stock currently trades at $326.15 with a market capitalization of $5.7B.


